USPTO serial 79158828
BIOMIMESYS
Reviewed by CopyMark Law Group
Reg. 5028994Status 707Renewal
- Filing date
- Status date
- Registration date
- Aug 30, 2016
- Examiner
- MORENO, PAUL A
- Law office
- TMEG LAW OFFICE 103
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with BIOMIMESYS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $1,700
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
G MATHEW LOMBARD
G MATHEW LOMBARD LOMBARD & GELIEBTER LLP230 PARK AVE4 FLOOR WESTNEW YORK, NY 10169Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical and veterinary products, namely, matrix for cell culture in the nature of cell growth media for growing cells for medical or clinical use, and for injectable biological tissue fillers for medical and veterinary purposes in the field of scientific research, medicine and tissue engineering; plasters for medical purposes; chemical preparations for pharmaceutical or medical purposes, namely, matrix for cell culture in the nature of cell growth media for growing cells for medical or clinical use, and for injectable biological tissue fillers for medical and veterinary purposes in the field of scientific research, medicine and tissue engineering; amino acids for medical use; adhesive bands for medical purposes; bandages for dressings; biological preparations for medical and veterinary use, namely, biological preparations for use in cell culture in the field of scientific research, medicine and tissue engineering; stem cells for medical use and for veterinary use; chemical preparations for medical, pharmaceutical and veterinary use, namely, matrix for cell culture in the nature of cell growth media for growing cells for medical or clinical use, and for injectable biological tissue fillers for medical and veterinary purposes in the field of scientific research, medicine and tissue engineering; culture media for use in augmentation of bone and tissue for medical purposes; Culture media for medical use, namely, for cultivating human cells, namely, primary and stem cells; biological tissue cultures for medical use; biological tissue cultures for veterinary use; Diagnostic preparations for medical purposes, namely, for diseases detection; medicines for dental use; medicines for veterinary use; medicines for human medicine; chemical reagents for medical or veterinary use; hyaluronic acid and polylactic acid for pharmaceutical purposes | ACTIVE | — |
| 010 | [ Surgical, medical, dental and veterinary apparatus and instruments, namely, bone void filler consisting of synthetic materials; implants consisting of artificial materials; orthopedic bandages for joints, namely, orthopedic support bandages; surgical sponges; artificial skin for surgical use ] | SECTION 71 - CANCELLED | — |
| 042 | Evaluations, assessments and research in the fields of science and technology provided by engineers, namely, scientific research; research and development of new products for others; technical project study in the nature of chemical and biological project management services, namely, biological and chemical research and analysis; chemical analysis; chemical research; chemistry consultation; quality control for others; testing of materials; scientific study and research in the fields of scientific research and tissue engineering; scientific laboratory services; biological research; bacteriological research; cosmetic research; technical research in the field of scientific research and tissue engineering | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by HCS PHARMA
- Other trademarks owned by NETRI
- Other trademarks owned by CELENYS
- Other trademarks owned by CELENYS
- Other trademarks owned by CELENYS
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named BIOMIMESYS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 25, 2025 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Aug 30, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Oct 31, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Dec 18, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 14, 2023 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 14, 2023 | INPC | INVALIDATION PROCESSED | — |
| Nov 10, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 10, 2023 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 10, 2023 | NA15 | SEC. 15 ACKNOWLEDGEMENT - E-MAILED | — |
| Mar 10, 2023 | 15AK | REGISTERED - SEC. 15 ACKNOWLEDGED | — |
| Mar 10, 2023 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Mar 7, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Aug 29, 2022 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Aug 29, 2022 | E15R | TEAS SECTION 15 RECEIVED | — |
| Aug 30, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Nov 27, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 16, 2020 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 7, 2019 | CHLD | CHANGE OF OWNER RECEIVED FROM IB | — |
| Jun 16, 2017 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 23, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 1, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 1, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 30, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 30, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jul 8, 2016 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jun 22, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jun 22, 2016 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 14, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 14, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 25, 2016 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 25, 2016 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 25, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 9, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 28, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 28, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 28, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 28, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 28, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 4, 2016 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 29, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 29, 2016 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 29, 2016 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 29, 2016 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 29, 2016 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Aug 27, 2015 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Aug 27, 2015 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Aug 27, 2015 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jul 27, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 27, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 20, 2015 | ALIE | ASSIGNED TO LIE | — |
| Jul 10, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| Feb 11, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Feb 11, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 10, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 9, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 27, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 23, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 23, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 22, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |